Financial Reports Latest Updates Industry Maps Economic Calendar

Organogenesis Holdings Inc. (ORGO) Annual Reports

Q: Where can I read Organogenesis Holdings Inc. (ORGO) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

Organogenesis Holdings Inc. is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1661181 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$43.8M	$101.0M	-56.7%
Operating income	$-51.0M	$-12.6M	-305.5%
Net income	$-96.3M	$-9.4M	-925.0%
EPS (diluted)	$-0.77	$-0.10	-670.0%

Company guidance
	Period	Range
Revenue	FY2026	$179M – $215M

Figures are the company’s own outlook as stated in its earnings release, not analyst estimates.

Source: SEC EDGAR (XBRL company facts); guidance from Form 8-K Exhibit 99.1

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 43.8 mn Net income -96.3 mn

Show table：Income statement

Item	2016Q1	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	—	—	—	0	139	39.8	54.1	51.5	53.1	35.5	43.5	50.8	63.6	57.1	65.0	64.3	74.7	61.7	69.0	101	107	103	123	114	129	98.1	121	117	116	108	117	109	99.7	110	130	115	127	86.7	101	151	226	37.2	43.8
Gross profit	—	—	—	—	90.5	26.5	38.7	35.4	36.7	21.0	26.3	31.3	46.1	40.1	45.5	45.1	54.3	42.9	48.9	77.8	81.3	77.1	93.3	87.6	96.0	73.0	94.8	90.7	88.4	81.0	91.0	82.7	71.9	81.3	101	88.4	95.6	63.0	—	—	—	—	—
Operating income	-0.03	-0.02	0	-0.01	-1.30	-0.22	-0.22	-2.85	-2.40	-1.16	-0.94	-2.25	-4.48	-12.1	-7.32	-8.26	-1.75	-15.1	-2.25	23.0	21.8	12.6	23.6	16.3	20.4	0.87	11.9	1.78	8.72	-4.00	9.74	8.05	-1.27	-3.85	-13.9	6.24	10.2	-26.8	-12.6	20.7	63.3	-68.9	-51.0
Net income	-0.03	-0.02	0	-0.01	-0.18	0.14	0.38	-2.12	-0.5	-0.14	0.36	4.94	-9.26	-15.7	-9.65	-10.7	-4.40	-16.3	-5.17	20.9	18.5	9.94	20.7	12.6	51.7	0.09	8.74	0.22	7.49	-2.97	5.32	3.17	-0.57	-2.10	-17.0	12.3	7.67	-18.8	-9.39	21.6	43.7	-53.2	-96.3

Balance sheet

Quarterly · In mn (USD)

Total assets 406 mn Total liabilities 118 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2016Q1	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	0.13	—	—	—	1.44	0.88	0.6	0.36	0.29	0.27	0.16	0.03	71.1	85.1	76.2	80.8	126	111	118	129	174	185	202	212	227	218	232	231	223	217	216	226	225	227	234	239	286	268	260	300	362	269	200
Total assets	0.42	—	—	0.82	311	311	312	312	313	314	315	316	164	176	168	175	221	208	216	246	294	319	356	370	443	436	456	457	449	446	450	463	460	458	443	446	498	467	461	510	599	520	406
Current liabilities	0.42	—	—	0.85	0.48	0.14	0.09	2.70	3.93	5.06	5.90	8.01	66.4	52.3	50.4	56.7	59.9	54.8	66.1	66.3	68.2	74.0	84.5	81.0	82.0	76.8	88.2	89.3	75.0	76.1	73.5	81.5	80.5	82.8	85.7	77.3	77.5	65.0	65.8	90.3	100	76.0	57.0
Total liabilities	0.42	—	—	—	11.3	11.0	10.9	13.6	14.8	15.9	16.8	13.1	117	144	145	162	165	168	181	181	148	162	177	181	201	193	202	201	184	182	179	186	181	180	180	168	113	99.3	99.9	124	165	139	118
Equity	0	—	—	-0.03	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	47.0	32.6	23.2	12.8	55.6	40.3	35.8	65.5	146	157	179	189	242	243	254	256	266	264	271	277	279	278	264	279	263	243	233	255	300	245	148

Cash flow

Quarterly · In mn (USD)

Operating -31.6 mn Investing -1.10 mn Financing -12.5 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2016Q1	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-0.02	0	—	-0.02	-0.54	-0.13	0.18	-0.54	-0.09	-0.23	-0.21	-0.29	-60.0	-9.56	-12.1	-5.45	-6.40	-17.3	-9.34	7.14	26.3	-1.48	17.7	27.9	17.9	1.41	10.2	5.45	7.80	-5.08	8.65	16.7	10.6	-10.2	4.74	8.70	10.9	-19.9	-32.9	3.08	39.4	21.1	-31.6
Investing	—	—	—	—	-310	—	-0.37	—	-14.5	-0.06	-0.49	-0.94	-0.36	-0.32	-1.18	-1.27	-3.46	-4.24	-1.87	-10.2	-8.48	-4.78	-4.51	-16.7	-5.23	-6.67	-6.17	-10.4	-10.7	-7.56	-7.50	-5.98	-3.32	-2.22	-1.88	-2.57	-3.36	-3.63	-3.64	-2.23	-4.65	-3.15	-1.10
Financing	0.14	-0.02	0	0.09	311	-0.43	0	0	0.1	0.2	0.18	0.23	81.0	19.1	2.80	9.73	47.1	8.23	4.89	-0.77	30.1	-0.59	-0.8	1.27	-0.92	-0.76	0.42	0.03	-1.87	-1.24	-1.05	-1.44	-1.78	-2.61	-1.73	-1.68	33.6	-2.06	-0.29	-10.2	-4.81	-20.2	-12.5
Cash at period end	1.20	—	—	—	1.86	—	—	—	2.36	0.92	1.31	25.9	21.4	30.7	20.2	23.2	60.4	47.1	40.8	36.9	84.4	78.0	90.3	103	114	108	112	107	102	88.7	88.9	98.2	104	88.6	89.9	94.3	136	110	73.1	63.8	93.7	91.4	46.1

Profitability

Quarterly · %

Gross margin 72.6% Operating margin -116.5% Net margin -220.0%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2016Q1	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	—	—	—	—	65.3%	66.6%	71.5%	68.7%	69.1%	59.1%	60.3%	61.6%	72.5%	70.3%	70.1%	70.2%	72.7%	69.6%	70.9%	77.2%	76.1%	75.1%	75.7%	77.0%	74.6%	74.4%	78.0%	77.6%	76.5%	75.3%	77.6%	76.2%	72.1%	73.9%	77.6%	76.7%	75.5%	72.6%	—	—	—	—	—
Operating margin	—	—	—	—	-0.9%	-0.6%	-0.4%	-5.5%	-4.5%	-3.3%	-2.2%	-4.4%	-7.0%	-21.2%	-11.3%	-12.9%	-2.4%	-24.4%	-3.3%	22.8%	20.4%	12.3%	19.1%	14.3%	15.9%	0.9%	9.8%	1.5%	7.5%	-3.7%	8.3%	7.4%	-1.3%	-3.5%	-10.7%	5.4%	8.1%	-30.9%	-12.4%	13.7%	28.1%	-185.1%	-116.5%
Net margin	—	—	—	—	-0.1%	0.3%	0.7%	-4.1%	-0.9%	-0.4%	0.8%	9.7%	-14.6%	-27.4%	-14.9%	-16.7%	-5.9%	-26.4%	-7.5%	20.8%	17.3%	9.7%	16.8%	11.1%	40.2%	0.1%	7.2%	0.2%	6.5%	-2.8%	4.5%	2.9%	-0.6%	-1.9%	-13.1%	10.7%	6.1%	-21.7%	-9.3%	14.3%	19.4%	-142.8%	-220.0%

Returns & leverage

Quarterly · %

ROE -44.1% ROA -19.4% Debt ratio 29.1%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2016Q1	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	-8.3%	-1.1%	6.6%	-71.4%	-41.9%	-47.4%	-47.9%	93.2%	-15.8%	-104.5%	-210.2%	-508.9%	-78.8%	-112.8%	-124.2%	-12.6%	17.8%	44.7%	65.3%	48.5%	48.9%	42.5%	33.7%	27.3%	6.5%	5.3%	3.8%	4.9%	1.8%	2.1%	-6.2%	-2.7%	0.3%	-6.1%	-3.3%	0.4%	13.2%	1.1%	-44.1%
ROA	—	—	—	-6.8%	-0.1%	-0.0%	0.1%	-1.1%	-0.7%	-0.8%	-0.8%	1.5%	-1.7%	-8.0%	-12.3%	-18.5%	-21.1%	-21.4%	-19.0%	-2.4%	7.0%	16.8%	24.5%	20.0%	25.7%	22.5%	18.0%	14.7%	3.7%	3.0%	2.2%	2.8%	1.1%	1.3%	-3.7%	-1.6%	0.2%	-3.4%	-1.8%	0.2%	6.8%	0.6%	-19.4%
Debt ratio	100.0%	—	—	—	3.6%	3.5%	3.5%	4.3%	4.7%	5.1%	5.3%	4.2%	71.3%	81.5%	86.2%	92.7%	74.8%	80.7%	83.5%	73.4%	50.4%	50.7%	49.7%	48.9%	45.4%	44.3%	44.3%	43.9%	40.9%	40.9%	39.8%	40.2%	39.4%	39.4%	40.5%	37.6%	22.6%	21.3%	21.7%	24.3%	27.5%	26.7%	29.1%

EPS

Quarterly · US$

EPS US$-0.77

Show table：EPS

Item	2016Q1	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	—	—	—	0.02	0.00	-0.08	-0.07	—	—	—	-0.94	—	—	-0.12	-0.04	-0.16	-0.05	0.19	0.17	0.07	0.15	0.09	0.39	0.00	0.07	0.00	0.06	-0.02	0.04	0.02	0.00	-0.02	-0.13	0.09	0.04	-0.17	-0.10	0.11	0.27	-0.44	-0.77

Revenue & profit

Year-to-date · In mn (USD)

Revenue 81.0 mn Net income -149 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 406 mn Total liabilities 118 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -10.5 mn Investing -4.25 mn Financing -32.7 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 72.6% Operating margin -148.0% Net margin -184.5%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -44.1% ROA -19.4% Debt ratio 29.1%

EPS

Year-to-date · US$

EPS US$-1.21

Revenue & profit

Annual · In mn (USD)

Revenue 564 mn Net income 37.0 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	—	199	193	261	338	468	452	433	482	564
Gross profit	—	137	125	185	251	354	347	327	366	—
Operating income	-1.35	-5.70	-8.83	-29.5	27.4	72.9	23.3	12.5	-1.28	44.7
Net income	-0.23	-2.09	-4.10	-40.5	17.9	94.9	16.5	4.95	0.86	37.0

Balance sheet

Annual · In mn (USD)

Total assets 599 mn Total liabilities 165 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	1.44	0.29	71.1	126	174	227	223	225	286	362
Total assets	311	313	164	221	294	443	449	460	498	599
Current liabilities	0.48	3.93	66.4	59.9	68.2	82.0	75.0	80.5	77.5	100
Total liabilities	11.3	14.8	117	165	148	201	184	181	113	165
Equity	5.00	5.00	47.0	55.6	146	242	266	279	263	300

Cash flow

Annual · In mn (USD)

Operating -10.3 mn Investing -14.2 mn Financing -17.4 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	—	-0.59	-60.7	-33.5	6.80	62.0	24.9	30.9	14.2	-10.3
Investing	—	—	-1.86	-6.23	-24.8	-31.2	-33.9	-24.4	-10.0	-14.2
Financing	312	-0.33	81.6	78.7	42.5	-1.04	-2.20	-5.50	27.6	-17.4
Cash at period end	1.86	2.36	21.4	60.4	84.4	114	102	104	136	93.7

Profitability

Annual · %

Gross margin 76.0% Operating margin 7.9% Net margin 6.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Gross margin	—	69.2%	64.4%	70.9%	74.2%	75.6%	76.8%	75.4%	76.0%	—
Operating margin	—	-2.9%	-4.6%	-11.3%	8.1%	15.6%	5.2%	2.9%	-0.3%	7.9%
Net margin	—	-1.1%	-2.1%	-15.5%	5.3%	20.3%	3.7%	1.1%	0.2%	6.6%

Returns & leverage

Annual · %

ROE 13.2% ROA 6.8% Debt ratio 27.5%

Show table：Returns & leverage

Item	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	-4.7%	-41.9%	-15.8%	-78.8%	17.8%	48.9%	6.5%	1.8%	0.3%	13.2%
ROA	-0.1%	-0.7%	-1.7%	-21.1%	7.0%	25.7%	3.7%	1.1%	0.2%	6.8%
Debt ratio	3.6%	4.7%	71.3%	74.8%	50.4%	45.4%	40.9%	39.4%	22.6%	27.5%

EPS

Annual · US$

EPS US$0.11

Show table：EPS

Item	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	-0.13	—	—	0.15	0.70	0.13	0.04	-0.02	0.11

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read Organogenesis Holdings Inc. (ORGO) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.